Conquest® content of high molecular weight hyaluronic acid provides an lubricating and shock absorbing effect while contributing to new production of hyaluronic acid in the joint. Conquest also contains Boswellia Serrata which prevents the hyaluronic acid from breaking down. Together, the substances have a synergistic effect and contribute to the presence of high quality hyaluronic acid. This helps the horse's joints to maintain a normal function and desired mobility.

Conquest® Start-Up EV10 is an oral paste given directly in the horse's mouth, advanced by veterinarians. 
 
Content:
Conquest® Start-up contains an extra high amount of hyaluronic acid (300mg/dose) and Boswella Serrata (1250mg/dose) which is a herb with circulatory, inflammatory and analgesic properties.

Dosage:
15g/day per 500kg body weight
A syringe Conquest Start-Up contains 45g which equals 3 doses to a 500kg horse.

Waiting period: 96 h

Conquest as aftercare

Very good results have been seen from giving a Conquest recovery course as aftercare after injected treatments in joints. The high molecular hyaluronic acid (HA) in the product contributes to new production of high molecular HA in the joint capsule cells. Boswellia Serratan inhibits the breakdown (of HA) caused by the ongoing inflammation. Friska Leder recommends giving the treated horse a course of Conquest (lasts for 2 months and consists of 2 Start Up syringes and 1 bottle of Follow Up).